Eden Biologics
Hsinchu
About Eden Biologics
Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development to commercial manufacturing with both global and regional regulatory affairs expertise.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $266.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2018)
- Ticker: tpe:6540
- Website: edenbiologics.com
- Phone: +886 3 658 3899
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/eden-biologics-162892 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.